Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Nabriva Therapeutics plc | nbrv-20191231ex322b6271b.htm |
| EX-32.1 - EX-32.1 - Nabriva Therapeutics plc | nbrv-20191231ex321ee4ac4.htm |
| EX-31.2 - EX-31.2 - Nabriva Therapeutics plc | nbrv-20191231ex312f8ca0c.htm |
| EX-31.1 - EX-31.1 - Nabriva Therapeutics plc | nbrv-20191231ex31146f075.htm |
| EX-23.1 - EX-23.1 - Nabriva Therapeutics plc | nbrv-20191231ex231e57868.htm |
| EX-10.43 - EX-10.43 - Nabriva Therapeutics plc | nbrv-20191231ex1043e47e7.htm |
| EX-10.42 - EX-10.42 - Nabriva Therapeutics plc | nbrv-20191231ex10422023b.htm |
| EX-10.41 - EX-10.41 - Nabriva Therapeutics plc | nbrv-20191231ex10413d837.htm |
| EX-10.40 - EX-10.40 - Nabriva Therapeutics plc | nbrv-20191231ex1040eec2b.htm |
| EX-10.10 - EX-10.10 - Nabriva Therapeutics plc | nbrv-20191231ex1010572b8.htm |
| EX-4.1 - EX-4.1 - Nabriva Therapeutics plc | nbrv-20191231ex41754b094.htm |
| 10-K - 10-K - Nabriva Therapeutics plc | nbrv-20191231x10k.htm |
Exhibit 21.1
SUBSIDIARIES OF NABRIVA THERAPEUTICS plc
|
Nabriva Therapeutics GmbH |
|
Austria |
|
|
|
|
|
Nabriva Therapeutics Ireland Designated Activity Company |
|
Ireland |
|
|
|
|
|
Zavante Therapeutics, Inc. |
|
United States |
|
|
|
|
|
Nabriva Therapeutics US, Inc. |
|
United States |